Literature DB >> 8242970

Successful treatment of amoebic meningoencephalitis in a Chinese living in Hong Kong.

A Wang1, R Kay, W S Poon, H K Ng.   

Abstract

Primary amoebic meningoencephalitis due to Naegleria fowleri was found in a 38-year-old Chinese man living in Hong Kong who presumably acquired the infection from swimming in a hot spring in neighbouring China. Amoebic cysts were identified in tissue taken from a brain abscess. The patient responded to surgical drainage and a 6-week course of amphotericin B, rifampicin and chloramphenicol. This is one of 6 cases of successful treatment of primary amoebic meningoencephalitis documented in the medical literature.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242970     DOI: 10.1016/0303-8467(93)90132-z

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  16 in total

1.  Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Soltow; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

Review 2.  Naegleria fowleri: pathogenesis, diagnosis, and treatment options.

Authors:  Eddie Grace; Scott Asbill; Kris Virga
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

3.  Vaccination with lentiviral vector expressing the nfa1 gene confers a protective immune response to mice infected with Naegleria fowleri.

Authors:  Jong-Hyun Kim; Hae-Jin Sohn; Jinyoung Lee; Hee-Jong Yang; Yong-Joon Chwae; Kyongmin Kim; Sun Park; Ho-Joon Shin
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

4.  Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.

Authors:  Jong-Hyun Kim; Suk-Yul Jung; Yang-Jin Lee; Kyoung-Ju Song; Daeho Kwon; Kyongmin Kim; Sun Park; Kyung-Il Im; Ho-Joon Shin
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

Review 5.  Review of clinical presentations in Thai patients with primary amoebic meningoencephalitis.

Authors:  Viroj Wiwanitkit
Journal:  MedGenMed       Date:  2004-03-08

6.  Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Goswick; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

7.  Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro.

Authors:  Jose Ignacio Escrig; Hye Jee Hahn; Anjan Debnath
Journal:  ACS Chem Neurosci       Date:  2020-05-26       Impact factor: 4.418

8.  Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.

Authors:  Anjan Debnath; Josefino B Tunac; Silvia Galindo-Gómez; Angélica Silva-Olivares; Mineko Shibayama; James H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

9.  Naegleria fowleri after 50 years: is it a neglected pathogen?

Authors:  Moisés Martínez-Castillo; Roberto Cárdenas-Zúñiga; Daniel Coronado-Velázquez; Anjan Debnath; Jesús Serrano-Luna; Mineko Shibayama
Journal:  J Med Microbiol       Date:  2016-07-04       Impact factor: 2.472

10.  Diagnosis of infections caused by pathogenic free-living amoebae.

Authors:  Bruno da Rocha-Azevedo; Herbert B Tanowitz; Francine Marciano-Cabral
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.